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1015-9584/Copyright ª 2015, Asian Su
NC-ND license (http://creativecommoSummary Objective: To establish better management practices to reduce morbidities in sur-
vivors with congenital diaphragmatic hernia (CDH).
Methods: Of 60 patients treated for CDH at our institution between 1991 and 2011, 49 patients
without severe anomalies were retrospectively reviewed.
Results: Since 2004, gentle ventilation (GV) has been the main treatment for CDH. Patients
were divided into the following two groups: the non-GV group (n Z 29) who were treated
before GV treatment was implemented, and the GV group (n Z 20). The overall survival rate
was 62.1% (18/29) and 95% (19/20) in the non-GV and GV groups, respectively (p Z 0.016).
Despite the high survival rate, the incidence of long-term complications in survivors was still
high (14/19, 73.7%) in the GV group. In the GV group, liver-up (p Z 0.106) and the need for
patch repair (p Z 0.257) tended to be associated with the development of long-term compli-
cations, but did not reach statistical significance. The presence of perioperative complications
was associated with the development of long-term complications (pZ 0.045) in the GV group.
Conclusion: Patients who developed short-term complications seemed to be at risk of long-
term complications. Therefore, to minimize long-term morbidities in CDH survivors, the pre-
vention of short-term complications might be important.
Copyright ª 2015, Asian Surgical Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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Table 1 Outcome in study groups.
Non-GV group GV group p
Overall survival 62.1 (18/29) 95.0 (19/20) 0.016
Survived at 90 d of birth 72.4 (21/29) 95.0 (19/20) 0.064
Values in bold indicate values with significant difference.
Data are presented as % (n).
GV Z gentle ventilation.
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Congenital diaphragmatic hernia (CDH) is one of the most
challenging anomalies faced by pediatric surgeons and
neonatologists. Recently, especially over the past 2 decades,
many innovative techniques, including high-frequency
oscillation (HFO), inhaled nitric oxide, extracorporeal
membrane oxygenation, and gentle ventilation (GV), have
been introduced as suitable options for CDH treatment.1e5 In
addition, prenatal diagnosis has also contributed to
improvement in the outcome of CDH.2,3 Currently, reports
from a number of highly qualified centers show remarkable
improvement in the survival rates, reported to be as high as
80%.1,5,6 By contrast, in follow-up studies of infants with
CDH, many complications, such as pulmonary damage, car-
diovascular diseases, gastrointestinal diseases, failure to
thrive, neurocognitive defects, and musculoskeletal abnor-
malities, have been described.7e12 With improved manage-
ment of infants with CDH, there has been an increase in
morbidities among long-term survivors. Thus, we must now
concentrate not only on the survival of infants with CDH but
also on morbidities in surviving patients. Although some re-
ports have addressed the issue of long-term outcomes for
CDH survivors,7e11,13e16 the variations in patient pop-
ulations, management, and length of follow up make it
difficult to draw firm conclusions about the quality of life of
these patients. The aim of this study is to show the long-term
functional impact of CDH repair on the survivors in a single-
institution cohort of newborns over a 20-year period.
2. Methods
A retrospective chart review was conducted on isolated
prenatally diagnosed CDH patients born during the period
between 1991 and 2011. Inclusion criteria were the pres-
ence of a CDH without associated life-threatening or
chromosomal anomalies. From 2004 to the present, a
combination of GV and a delayed operation was the main
treatment after birth. GV was performed based on the
protocol presented by one of the study authors.4 The pa-
tient was intubated just after birth. The initial settings of
HFO were as follows: frequency, 15 Hz; mean airway
pressure, 15 cmH2O; stroke volume, 15 mL; and inspired O2
fraction (FiO2), 1.0. The pre-SpO2 (saturation of peripheral
oxygen) was maintained at >90% and the pre-PaCO2
(pressure of arterial carbon dioxide) was maintained at
<65 mmHg. In addition, the pre-PaO2 (pressure of arterial
oxygen) was maintained above 60 mmHg, if possible.
Liver position was determined at the time of surgery. A
systematic review was conducted including the following
data: gestational age at diagnosis, position of the liver,
postnatal treatment, need for patch repair, duration of
ventilation, perioperative complications, long-term com-
plications, and survival. Liver position is considered to be
“up” if any portion of the liver is in the chest above the
normal level of the diaphragm, and “down” if it is
completely within the abdomen. Major morbidities at
discharge included the need for respiratory support (sup-
plemental oxygen, mechanical ventilation, and tracheos-
tomy), nutritional support (tube feeding and parenteral
nutrition), or circulatory support (use of vasodilators).Statistical analysis was performed to assess the patients’
backgrounds in the non-GV and GV groups using the Wil-
coxon signed-rank test and Fisher exact test. Univariate
analyses were also performed for comparison of the out-
comes in the non-GV and GV groups using the Wilcoxon
signed-rank test and Fisher exact test. A p value <0.05 was
defined as significant. The values are expressed as the
mean  standard deviation. This study design was approved
by the Ethical Committee of our university.
3. Results
We retrospectively reviewed 60 neonates with CDH treated
at our institution from 1991 to 2011. Of these neonates, one
who became symptomatic more than 24 hours after birth,
and 10 with fatal anomalies were excluded, leaving 49
patients for review in this study. The patients were divided
into two groups, namely, the non-GV group (n Z 29) who
were treated before GV was implemented and the GV group
(n Z 20) who were treated after GV was implemented.
3.1. Survival
Table 1 shows the outcomes in both groups. The overall
survival rate improved with GV treatment (non-GV group
62.1%, GV group 95%; p Z 0.016). The 90-day survival rate
also improved with GV treatment, but did not reach sta-
tistical significance (non-GV group 72.4%, GV group 95%;
pZ 0.064). In the non-GV group, eight patients died before
90 days of life. The causes of deaths were heart failure in
four cases, severe persistent pulmonary hypertension in
one case, pneumonia in one case, and diffuse intravascular
coagulation in two cases. Six of these eight cases were
outborn deliveries and two of them were already in a state
of cardiopulmonary arrest when they arrived at our insti-
tution. Only one patient died in the GV group, due to
catheter infection-related sepsis at 68 days of life after the
surgery. There were three late death cases after 90 days of
life in the non-GV group and are attributed to the following
causes: pneumonia at 1 year of age, severe enteritis at 1
year of age, and tracheostomy trouble at 16 years of age.
There were no late death cases in the GV group.
3.2. Perioperative and long-term complications
The perioperative and long-term complications in both
groups are listed in Tables 2 and 3, respectively. The inci-
dence of perioperative complications was 13/29 (44.8%)
patients and 9/20 (45.0%) patients in the non-GV and GV
groups, respectively. The incidence of long-term
Table 2 Perioperative complications in the study groups.
Complications Non-GV group
(n Z 29)
GV group
(n Z 20)
p
Pneumothorax 2 (6.9) 2 (10.0) >0.999
Pneumonia 2 (6.9) 1 (5.0) >0.999
PPHN attack 1 (3.4) 0 (0.0) >0.999
Pulmonary hemorrhage 1 (3.4) 0 (0.0) >0.999
Chylothorax 0 (0.0) 2 (10.0) 0.162
Pleural effusion 0 (0.0) 1 (5.0) 0.229
Pyothorax 0 (0.0) 1 (5.0) 0.229
Others 7 (24.1) 2 (10.0) 0.277
Any complications 13 (44.8) 9 (45.0) >0.999
Data are presented as n (%).
GV Z gentle ventilation; PPHN Z persistent pulmonary hy-
pertension of the newborn.
Table 4 Major morbidities at discharge in both groups.
Morbidities Non-GV (n Z 21) GV (n Z 19) p
Tracheostomy 2 (9.5) 0 (0) 0.489
Supplemental O2 2 (9.5) 3 (15.8) 0.654
Tube feeding 2 (9.5) 5 (26.3) 0.226
Vasodilators 0 (0) 4 (21.1) 0.042
Any morbidities 3 (14.3) 6 (31.6) 0.442
Values in bold indicate the values with significant difference.
Many patients listed were discharged with more than two
morbidities.
Data are presented as n (%).
GV Z gentle ventilation.
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patients in the non-GV and GV groups, respectively. Of the
13 patients who developed perioperative complications in
the non-GV group, six patients died before 90 days of life
and six patients suffered from long-term morbidities
including three late deaths. Of the nine patients who
developed perioperative complications in the GV group,
one patient died before 90 days of life and eight patients
suffered from long-term complications.
Details of the major morbidities of the patients at
discharge are presented in Table 4. Many of them suffered
from more than two major morbidities at discharge. At
discharge, four patients in the non-GV group and three in
the GV group needed respiratory support (tracheostomy
and supplemental O2). The number of patients discharged
that required tube feeding was two in the non-GV group and
five in the GV group. There were no patients discharged
that required supplementation of vasodilators in the non-
GV group because vasodilators were not administrated
routinely during the non-GV period. Four patients wereTable 3 Long-term complications in both groups.
Complications Non-GV
(10/21)
GV (14/19) p
Mental retardation 3 (14.3) 9 (47.4) 0.038
Failure to thrive 2 (9.5) 5 (26.3) 0.226
Intestinal
obstruction
5 (23.8)
(Operation 5)
2 (10.5)
(Operation 1)
0.412
GER 2 (9.5)
(Operation 2)
4 (21.1)
(Operation 2)
0.398
Hearing loss 0 (0) 1 (5.2) 0.475
Chest wall
deformities
2 (9.5) 2 (10.5) >0.999
Others 3 (14.3)
(Death in
late term 3)
1 (5.2)
(Recurrence 1)
0.607
Any morbidities 10 (47.6) 14 (73.7) 0.117
Values in bold indicate the values with significant difference.
Data are presented as n (%).
GER Z gastroesophageal reflux; GV Z gentle ventilation.discharged with supplementation of vasodilators in the GV
group. Indication for vasodilators depended on the sur-
geon’s individual decision. Three of these four patients
were not using vasodilators at the time of writing. Three of
21 survivors (14.3%) in the non-GV group were discharged
with major morbidities. By contrast, six of 19 survivors
(31.6%) in the GV group were discharged with major mor-
bidities. Thus, the rates of the patients at discharge
without major morbidities were 62.1% (18/29 patients) and
65.0% (13/20 patients) in the non-GV and GV groups,
respectively. Of patients without major morbidities at
discharge, 10/18 (55.5%) patients and 5/13 (38.5%) patients
in the non-GV and GV groups, respectively, survived without
developing long-term complications.3.3. Predictors for long-term complications
Although the survival rate has improved after the admin-
istration of GV, the incidence of long-term complications
has remained high. To investigate the predictors for long-
term complications in the GV group, we examined the
associated disease’s severity and long-term complications
with regard to liver position and the need for patch repair
in the GV group. As demonstrated in Table 5, liver-up
(p Z 0.106), the need for patch repair (p Z 0.257), and
the existence of major morbidities at discharge (pZ 0.126)
tended to be associated with the development of long-termTable 5 Incidence of long-term complications in patients
with liver-up, patch repair, perioperative complications,
and major morbidities at discharge in the gentle ventilation
group.
Long-term
complications
(þ)
Long-term
complications
()
p
Liver-up 50 (7/14) 0 (0/5) 0.106
Patch repair 36 (5/14) 0 (0/5) 0.257
Major morbidities
at discharge
42.9(6/14) 0 (0/5) 0.126
Perioperative
complications
57 (8/14) 0 (0/5) 0.045
Values in bold indicate the values with significant difference.
Data are presented as % (n).
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The presence of perioperative complications was associ-
ated with the development of long-term complications
(p Z 0.045). Of interest, all patients without the studied
risk factors mentioned earlier were free from long-term
complications.
The duration of mechanical ventilation indicates the
disease severity especially in the perioperative period. In
addition, patients with perioperative complications may
need prolonged respiratory support. Therefore, we hy-
pothesized that the duration of mechanical ventilation is
predictive of long-term complications. As shown in Fig. 1,
the duration of mechanical ventilation was significantly
shorter in the patients without long-term complications in
the GV group (6.00  3.17 days and 48.9  11.95 days in the
patients without and with long-term complications,
respectively; p Z 0.016).4. Discussion
As more children with severe forms of CDH survive, more
cases of CDH-associated complications will occur. The in-
crease in CDH patient survival shifts the focus to improving
survivor morbidity, because CDH survivors have a high
incidence of respiratory, nutritional, musculoskeletal,
neurological, and gastrointestinal morbidities.2,3,7e17 In our
series, 31.6% (6/19) of patients were discharged with major
morbidities (3 on supplemental O2, 5 requiring tube
feeding, and 4 received vasodilators) even after imple-
mentation of GV. In addition, the majority of patients
developed long-term complications (Table 3), especially in
the GV group, in which 73.7% (14/19) of the survivors suf-
fered from long-term complications even though the sur-
vival rate improved to as high as 95% (19/20 patients).
Recently, several reports mentioned the precise inci-
dence patterns of morbidities in CDH survivors. Okuyama
et al5 reported that the rate of growth and motor/speech
retardation was 44% and 80% in intact discharge patients
and nonintact discharge patients, respectively, at 1 year
and 6 months of age. Rocha et al10 reported that the rate of
CDH survivors with one morbidity, two morbidities, andFigure 1 Duration of mechanical ventilation and long-term
complications in the gentle ventilation group. Duration of
mechanical ventilation was significantly shorter in patients
without long-term complications.more than three morbidities was 15.6%, 15.3%, and 20.2%,
respectively. Based on our results and these reports, sig-
nificant numbers of CDH patients may live with complica-
tions, resulting in poor quality of life.2,3,9,13,15,16 In
particular, the incidence of mental retardation was signif-
icantly higher in the GV group. This is not only due to the
improved survival rate but also due to a much longer and
more closely monitored follow-up program started recently
in our study.
To reduce the incidence of long-term complications, we
investigated the predictors for long-term complications in
the GV group. Large hernia size, patch repair, and liver
herniation are reported to be significant predictors of sur-
gical complications and long-term adverse outcomes.11,18,19
In the present study, all the patients in the liver-up and
patch repair groups had long-term complications (Table 5).
The cases with liver-up (p Z 0.106) and patch repair
(p Z 0.257) seemed to be at risk of long-term complica-
tions, but did not reach statistical significance (Table 5).
From our observations, perioperative complications seem
to be important risk factors for long-term complications to
improve the long-term outcome of the CDH survivors. In the
GV group, we evaluated the association between periop-
erative complications and long-term complications. Of 14
patients who developed long-term complications, eight had
perioperative complications. By contrast, all five disease-
free survivors experienced no perioperative complica-
tions. Patients who developed perioperative complications
seemed to be at risk of long-term complications (pZ 0.045,
Table 5). Interestingly, the duration of mechanical venti-
lation was significantly shorter in the patients without long-
term complications (Fig. 1). Not alone the severity of the
disease, but also the perioperative complications may
prolong the duration of mechanical ventilation. Pneumo-
thorax, empyema, and pneumonia can especially cause
prolonged intubation. Based on our result, perioperative
management to prevent such complications might be a key
to reducing the incidence of long-term complications. In
addition, we have to pay increased attention to patients
who developed perioperative complications even after
discharge because they seem to be at risk of long-term
complications.
In the present study, the survival rate of patients with
CDH improved using the GV protocol. However, in accor-
dance with other previous reports, the incidence of long-
term morbidities was still high.2,3,5,7e13,15,16 As the survival
rate increases, we have to focus on the long-term compli-
cations. The rescuing of more severely affected patients
results in more patients with severe morbidities. The more
carefully we track patients, the more adverse outcomes in
survivors we might find. For example, the incidence of
mental retardation significantly increased in the GV group.
The increase in mental retardation cases might be due to
the more complete and careful follow-up system. Based on
our results, besides indicated markers such as patch repair
and liver herniation, the risk of long-term morbidities was
high in patients with perioperative complications and
delayed extubation.
After discharge from hospital, CDH survivors may have
long-term sequelae such as respiratory insufficiency,
gastroesophageal reflux, failure to thrive, neuro-
developmental delay, behavior problems, hearing loss,
Analysis of risk factors of complications in CDH 5hernia recurrence, and orthopedic deformities.2,3,5,7e17
Underlying pulmonary hypoplasia and pulmonary hyper-
tension cause neurodevelopmental deficits including hear-
ing loss due to hypoxia or hypoperfusion associated with
pulmonary problems.8e13,15 In addition, surgical complica-
tions such as recurrence, small bowel obstruction, gastro-
esophageal reflux, and musculoskeletal problems occur in
CDH survivors.2,7e11,13,14,17 Both nutritional problems
resulting in neurodevelopmental deficits and surgical com-
plications may lead to failure to thrive.
Our study is limited by the relatively small number of the
patients studied. However, to describe the long-term
morbidities and to investigate risk factors for long-term
complications, a single institution’s study is informative
because the patients were treated by the same protocol in
the acute phase and followed by a unified follow-up
protocol.
Based on our study, it is important to recognize that CDH
survivors are unique because they are at high risk of
multisystem disability. Long-term follow up by a multidis-
ciplinary health-care team is essential to detect morbid-
ities early and to improve the long-term outcomes for CDH
survivors. Timely intervention for disabilities in growth,
neurodevelopment, and hearing is only possible if they are
recognized early in the follow-up process. Our data suggest
that to minimize morbidities, strict follow up with closer
evaluations is mandatory for patients who develop periop-
erative complications.
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